Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes von Van Hees, Steffi, Bourgeois, Sabine, Van Vlierberghe, H, Sersté, T, Francque, S, Michielsen, Paul, Sprengers, D, Reynaert, H, Henrion, J, Negrin Dastis, S, Delwaide, J, Lasser, L, Decaestecker, J, Orlent, H, Janssens, F, Robaeys, Geert, Colle, I, Stärkel, P, Moreno, C, Nevens, Frederik, Vanwolleghem, T

Volltext